1. Home
  2. ALT vs SES Comparison

ALT vs SES Comparison

Compare ALT & SES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • SES
  • Stock Information
  • Founded
  • ALT 1997
  • SES 2012
  • Country
  • ALT United States
  • SES United States
  • Employees
  • ALT N/A
  • SES N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • SES Auto Parts:O.E.M.
  • Sector
  • ALT Health Care
  • SES Consumer Discretionary
  • Exchange
  • ALT Nasdaq
  • SES Nasdaq
  • Market Cap
  • ALT 292.0M
  • SES 384.0M
  • IPO Year
  • ALT N/A
  • SES N/A
  • Fundamental
  • Price
  • ALT $3.83
  • SES $1.12
  • Analyst Decision
  • ALT Strong Buy
  • SES Hold
  • Analyst Count
  • ALT 6
  • SES 3
  • Target Price
  • ALT $17.40
  • SES $1.50
  • AVG Volume (30 Days)
  • ALT 3.0M
  • SES 5.6M
  • Earning Date
  • ALT 08-12-2025
  • SES 08-04-2025
  • Dividend Yield
  • ALT N/A
  • SES N/A
  • EPS Growth
  • ALT N/A
  • SES N/A
  • EPS
  • ALT N/A
  • SES N/A
  • Revenue
  • ALT $20,000.00
  • SES $11,360,000.00
  • Revenue This Year
  • ALT N/A
  • SES $883.92
  • Revenue Next Year
  • ALT $761,880.20
  • SES $159.98
  • P/E Ratio
  • ALT N/A
  • SES N/A
  • Revenue Growth
  • ALT N/A
  • SES N/A
  • 52 Week Low
  • ALT $2.90
  • SES $0.20
  • 52 Week High
  • ALT $11.16
  • SES $2.53
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • SES 51.03
  • Support Level
  • ALT $3.35
  • SES $1.09
  • Resistance Level
  • ALT $3.66
  • SES $1.22
  • Average True Range (ATR)
  • ALT 0.19
  • SES 0.07
  • MACD
  • ALT 0.07
  • SES -0.00
  • Stochastic Oscillator
  • ALT 86.18
  • SES 55.32

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About SES SES AI Corporation

SES AI Corp is a developer and manufacturer of high-performance, AI-enhanced Lithium-Metal (Li-Metal) and Lithium-ion (Li-ion) rechargeable battery technologies for electric vehicles (EVs), Urban Air Mobility (UAM), drones, robotics, Battery Energy Storage Systems (BESS) and other applications. It includes Software and Hardware products that are EV, UAM, Drone, Molecular Universe, and Avatar.

Share on Social Networks: